
The American Academy of HIV Medicine has certified thousands of providers with specialist or expert designations.

The American Academy of HIV Medicine has certified thousands of providers with specialist or expert designations.

Treatment dramatically reduces viral load in blood.

TAF shows signs of improved renal and bone parameters compared with Viread in clinical trials.




The FDA approved Triumeq (abacavir, dolutegravir, and lamivudine) tablets for the treatment of HIV-1 infection in patients without the HLA-B*5701 allele.

High cost of new drugs make treating even the sickest inmates impractical.

Gilead Sciences is seeking FDA approval for emtricitabine/tenofovir alafenamide.

Lack of adherence remains a major source of health care costs among HIV patients.

Accelerated aging of DNA can lead to diseases such as cancer and osteoporosis.

Vast majority of children with HIV experience recovery of immune system following therapy.

Combination fast-tracked for approval to treat chronic HCV GT1 infection in end-stage renal disease patients on hemodialysis.

While health care providers generally favor pre-exposure prophylaxis (PrEP) for patients at high risk of acquiring human immunodeficiency virus (HIV), many hesitate to actually prescribe it.

HIV antiviral therapy can prevent infection from establishing in at-risk individuals.

HIV patients need to have undetectable viral load to undergo procedure.

A New York pharmacist was sentenced to 3 years in prison and will have to pay more than $7 million in restitution for his scheme to defraud Medicare, Medicaid, and an AIDS program.

Moderate to intense exercise carries wide range of benefits.

Recent spike in HIV cases linked to intravenous drug use.

Risk of HIV transmission is higher in the acute phase than the chronic one.

The pharmacist's role as a disease educator is moving to the forefront.

Commonly cited estimates on how easily newly infected patients transmit HIV may be vastly overstated.

Nearly half of all infected patients not receiving medical care.

Study finds HIV-1 viral loads decreased following treatment with Valtrex.

A drug typically used to treat herpes may reduce HIV-1 levels, even in those who don't have herpes.